Clinical Trial: Ritlecitinib in CTCL
Study Status: Completed
Recruit Status: RECRUITING
Condition: CTCL
Study Type: INTERVENTIONAL
Official Title: A Single-center, Single-arm, Open-label Phase IIA Clinical Trial to Investigate Efficacy and Safety of Ritlecitinib (PF-06651600) in Patients With Cutaneous T Cell Lymphomas
Brief Summary:
The purpose of this research study is to evaluate the effectiveness and safety of Ritlecitinib in skin and blood in persons with Cutaneous T-Cell Lymphoma (CTCL).CTCL is a rare type of cancer that starts in the white blood cells and eventually can result in rashes or tumors in the skin.This study includes a 24 week Treatment Period and a 24 week Follow-up Period.This study will involve physical examinations, visual assessments, laboratory tests, PET-CT scans, electrocardiograms, photographs of your skin, skin…
Read more